Clinical Trials Browser

Phase 1/2 × Metastatic Castration-resistant Prostate Cancer × Abiraterone Acetate × Clear all

NCT05405439 2023-11-03

To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer

Phase 1/2 Terminated

Metastatic Castration-resistant Prostate Cancer